• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Bioxytran, University Of Minnesota Collaborate

    ACCESSWIRE

    Bioxytran Stroke & Alzheimer’s Tech Validated for Oxygen Uptake

    GLOBENEWSWIRE

    Bioxytran’s Antiviral Tech Part Of $100M HPAI Grant Bid

    GLOBENEWSWIRE

    Bioxytran Signs NDA With UGA To Study Bird Flu Treatment

    GLOBENEWSWIRE

    Bioxytran’s Cancer Preprint Reveal Potential to Immunotherapy Drug

    GLOBENEWSWIRE

    Bioxytran Forms JV With Heme Foundation For Universal Oxygen Carrier

    GLOBENEWSWIRE

    Bioxytran Announces Preprint of Shingles Case Study

    GLOBENEWSWIRE

    Bioxytran Interview at the Emerging Growth Conference

    GLOBENEWSWIRE

    Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M

    GLOBENEWSWIRE

    Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M

    GLOBENEWSWIRE

    Bioxytran Names Leslie Ajayi as Interim CMO & Head of the Medical Advisory Board

    GLOBENEWSWIRE

    Bioxytran Expands Investor Base with an additional $500,000 Equity Investment

    GLOBENEWSWIRE

    Bioxytran Interview at the Emerging Growth Conference

    GLOBENEWSWIRE

    Bioxytran Interview at the Emerging Growth Conference

    GLOBENEWSWIRE

    Bioxytran to Appear on ClearThink IR’s Virtual Live Event

    GLOBENEWSWIRE

    Bioxytran Interview at the Emerging Growth Conference

    GLOBENEWSWIRE

    Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization

    GLOBENEWSWIRE

    Bioxytran Interview at the Emerging Growth Conference

    GLOBENEWSWIRE

    Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients

    GLOBENEWSWIRE

    Bioxytran Announces the Reinitiation of Coverage of Stock by Avise Analytics

    GLOBENEWSWIRE

    Bioxytran Scientific Advisor Releases New Book on Brain Metabolism

    GLOBENEWSWIRE

    Novel Carbohydrate AVDC Acts Through Galectin Inhibition to Block Coronavirus

    GLOBENEWSWIRE

    Bioxytran Positioned to Detect and Treat Stroke and Neuropathologies

    GLOBENEWSWIRE

    Bioxytran Seeking Partners for Late Stage Treatment of Coronavirus using BXT-25

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.